Poland· PL-100448750
Laticort 0,1%
A hydrocortisone butyrate product containing hydrocortisoni butyras, registered in Poland by Aga Kommerz spol. s r.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hydrocortisone butyrate is registered in 13 of 19 countries.
Countries holding a registration under ATC D07AB02 (hydrocortisone butyrate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Hydrocortisone butyrate · ATC D07AB02
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Hydrocortisoni butyras
- Manufacturer
- Aga Kommerz spol. s r.o.
- Country
- Poland (PL)
- ATC code
- D07AB02
- ATC class
- Hydrocortisone butyrate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991449520
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for hydrocortisone butyrate.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydrocortisone butyrate · interactions on record
55 records
Same class
Other records under D07AB02
Hydrocortisone butyrate, as other registers publish it.
- NorwayAlfasonCheplapharm
- GermanyAlfason CreloCheplapharm Arzneimittel Gmbh
- GermanyAlfason CremeCheplapharm Arzneimittel Gmbh
- GermanyAlfason CresaCheplapharm Arzneimittel Gmbh
- GermanyAlfason CrinaleCheplapharm Arzneimittel Gmbh
- GermanyAlfason SalbeCheplapharm Arzneimittel Gmbh
- FinlandBucortOrion Corporation Orion Pharma
- FinlandBucortOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eeed0d1c-f8f2-453d-bf65-c95c548101bf GET /v1/drugs/eeed0d1c-f8f2-453d-bf65-c95c548101bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "1 mg/g",
"packaging": "05909991449520 ¦ Rp ¦ 139464\n1 tuba 15 g",
"substance": "Hydrocortisoni butyras 1 mg/g",
"common_name": "Hydrocortisoni butyras",
"pl_product_id": "100448750",
"pozwolenie_nr": "73/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-03-04"
}See everything about hydrocortisone butyrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.